Specific reversal agent for FXa - Inhibitor treatment - What the study data reveals? .

31 August 2019 (15:45 - 16:00)
Organised by:
Congress Presentation Part of: Paradigm shift in DOAC reversal - What are the current therapeutic options? Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Associate Professor E. Grove (Aarhus, DK)
Presentation thumbnail
Professor E. Lindhoff-Last (DE) Associate Professor E. Grove (Aarhus, DK)

The Event

Event poster

ESC Congress 2019

31 August 2019 15:45 CET